EZH2 and breast carcinoma: Both p38α knockdown using stable lentiviral-mediated short hairpin RNA interference (shRNA) and chemical inhibition of p38α/β activity with SB202190 significantly reduced pEZH2(T367) protein in breast cancer cells without affecting total levels of EZH2 and was accompanied by increased H3K27me3 levels (Fig. 2b).